The groundbreaking success of Sildenafil undeniably transformed the medication landscape, but betting in companies heavily reliant on off-patent versions presents a complex picture. Although early earnings were significant, the cessation of patents and the rise of discounted alternatives have eroded the customer base. Consequently, a thorough asses